Ingestion of the malaria pigment hemozoin renders human macrophages less permissive to HIV-1 infection

Virology

Volumn 395, Issue 1, 2009, Pages 56-66

  Diou, Juliette ^a   Gauthier, Sonia ^a   Tardif, Mélanie R ^a   Fromentin, Rémi ^a   Lodge, Robert ^a   Sullivan Jr , David J ^b   Tremblay, Michel J ^a  

^a LAVAL UNIVERSITY   (Canada)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Hemozoin; HIV; Macrophage; Malaria

Indexed keywords

HEMOZOIN; VIRUS DNA;

ANIMAL CELL; ARTICLE; CELL LINE; CELL VIABILITY; CHROMOSOME; CONFOCAL MICROSCOPY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LIFE CYCLE; MACROPHAGE; MALARIA FALCIPARUM; MIXED INFECTION; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PHAGOCYTOSIS; PLASMID; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SYNTHESIS; VIRUS ENTRY; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1; PLASMODIUM FALCIPARUM; PLASMODIUM PARASITES;

ANIMALS; CELL LINE; HEMEPROTEINS; HIV INFECTIONS; HIV-1; HUMANS; MACROPHAGES; MALARIA, FALCIPARUM; MICE; PHAGOCYTOSIS; PIGMENTS, BIOLOGICAL; PLASMODIUM FALCIPARUM; VIRUS REPLICATION;

EID: 72049089287     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.09.010     Document Type: Article

References (69)

1. Arese P., and Schwarzer E. Malarial pigment (haemozoin): a very active 'inert' substance. Ann. Trop. Med. Parasitol. 91 5 (1997) 501-516
2. Arfi V., Riviere L., Jarrosson-Wuilleme L., Goujon C., Rigal D., Darlix J.L., and Cimarelli A. Characterization of the early steps of infection of primary blood monocytes by human immunodeficiency virus type 1. J. Virol. 82 13 (2008) 6557-6565
3. Arhel N., Genovesio A., Kim K.A., Miko S., Perret E., Olivo-Marin J.C., Shorte S., and Charneau P. Quantitative four-dimensional tracking of cytoplasmic and nuclear HIV-1 complexes. Nat. Methods 3 10 (2006) 817-824
4. Arhel N., Munier S., Souque P., Mollier K., and Charneau P. Nuclear import defect of human immunodeficiency virus type 1 DNA flap mutants is not dependent on the viral strain or target cell type. J. Virol. 80 20 (2006) 10262-10269
5. Arhel N.J., Souquere-Besse S., Munier S., Souque P., Guadagnini S., Rutherford S., Prevost M.C., Allen T.D., and Charneau P. HIV-1 DNA Flap formation promotes uncoating of the pre-integration complex at the nuclear pore. EMBO J. 26 12 (2007) 3025-3037
6. Ayouba A., Badaut C., Kfutwah A., Cannou C., Juillerat A., Gangnard S., Behr C., Mercereau-Puijalon O., Bentley G.A., Barre-Sinoussi F., and Menu E. Specific stimulation of HIV-1 replication in human placental trophoblasts by an antigen of Plasmodium falciparum. AIDS 22 6 (2008) 785-787
7. Bergeron M., and Olivier M. Trypanosoma cruzi-mediated IFN-gamma-inducible nitric oxide output in macrophages is regulated by iNOS mRNA stability. J. Immunol. 177 9 (2006) 6271-6280
8. Bounou S., Leclerc J.E., and Tremblay M.J. Presence of host ICAM-1 in laboratory and clinical strains of human immunodeficiency virus type 1 increases virus infectivity and CD4(+)-T-cell depletion in human lymphoid tissue, a major site of replication in vivo. J. Virol. 76 3 (2002) 1004-1014
9. Breman J.G. The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden. Am. J. Trop. Med. Hyg. 64 1-2 Suppl (2001) 1-11
10. Brown W. Malarial pigment (so-called melanin): its nature and mode of production. J. Exp. Med. 13 2 (1911) 290-300
11. Bukrinskaya A., Brichacek B., Mann A., and Stevenson M. Establishment of a functional human immunodeficiency virus type 1 (HIV-1) reverse transcription complex involves the cytoskeleton. J. Exp. Med. 188 11 (1998) 2113-2125
12. Bukrinsky M.I., Sharova N., Dempsey M.P., Stanwick T.L., Bukrinskaya A.G., Haggerty S., and Stevenson M. Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc. Natl. Acad. Sci. U.S.A. 89 14 (1992) 6580-6584
13. Bukrinsky M.I., Sharova N., McDonald T.L., Pushkarskaya T., Tarpley W.G., and Stevenson M. Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. Proc. Natl. Acad. Sci. U.S.A. 90 13 (1993) 6125-6129
14. Campbell E.M., Nunez R., and Hope T.J. Disruption of the actin cytoskeleton can complement the ability of Nef to enhance human immunodeficiency virus type 1 infectivity. J. Virol. 78 11 (2004) 5745-5755
15. Chaisavaneeyakorn S., Moore J.M., Mirel L., Othoro C., Otieno J., Chaiyaroj S.C., Shi Y.P., Nahlen B.L., Lal A.A., and Udhayakumar V. Levels of macrophage inflammatory protein 1 alpha (MIP-1 alpha) and MIP-1 beta in intervillous blood plasma samples from women with placental malaria and human immunodeficiency virus infection. Clin. Diagn. Lab. Immunol. 10 4 (2003) 631-636
16. Chun T.W., Stuyver L., Mizell S.B., Ehler L.A., Mican J.A., Baseler M., Lloyd A.L., Nowak M.A., and Fauci A.S. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc. Natl. Acad. Sci. U.S.A. 94 24 (1997) 13193-13197
17. Coban C., Ishii K.J., Sullivan D.J., and Kumar N. Purified malaria pigment (hemozoin) enhances dendritic cell maturation and modulates the isotype of antibodies induced by a DNA vaccine. Infect. Immun. 70 7 (2002) 3939-3943
18. Depienne C., Mousnier A., Leh H., Le Rouzic E., Dormont D., Benichou S., and Dargemont C. Characterization of the nuclear import pathway for HIV-1 integrase. J. Biol. Chem. 276 21 (2001) 18102-18107
19. Dornadula G., Zhang H., Shetty S., and Pomerantz R.J. HIV-1 virions produced from replicating peripheral blood lymphocytes are more infectious than those from nonproliferating macrophages due to higher levels of intravirion reverse transcripts: implications for pathogenesis and transmission. Virology 253 1 (1999) 10-16
20. Fortin J.F., Cantin R., Lamontagne G., and Tremblay M. Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity. J. Virol. 71 5 (1997) 3588-3596
21. Froebel K., Howard W., Schafer J.R., Howie F., Whitworth J., Kaleebu P., Brown A.L., and Riley E. Activation by malaria antigens renders mononuclear cells susceptible to HIV infection and re-activates replication of endogenous HIV in cells from HIV-infected adults. Parasite Immunol. 26 5 (2004) 213-217
22. Hameau L., Jeusset J., Lafosse S., Coulaud D., Delain E., Unge T., Restle T., Le Cam E., and Mirambeau G. Human immunodeficiency virus type 1 central DNA flap: dynamic terminal product of plus-strand displacement DNA synthesis catalyzed by reverse transcriptase assisted by nucleocapsid protein. J. Virol. 75 7 (2001) 3301-3313
23. Hearps A.C., and Jans D.A. HIV-1 integrase is capable of targeting DNA to the nucleus via an importin alpha/beta-dependent mechanism. Biochem. J. 398 3 (2006) 475-484
24. Hempelmann E. Hemozoin biocrystallization in Plasmodium falciparum and the antimalarial activity of crystallization inhibitors. Parasitol. Res. 100 4 (2007) 671-676
25. Huy N.T., Trang D.T., Kariu T., Sasai M., Saida K., Harada S., and Kamei K. Leukocyte activation by malarial pigment. Parasitol. Int. 55 1 (2006) 75-81
26. Imbeault M., Lodge R., Ouellet M., and Tremblay M.J. Efficient magnetic bead-based separation of HIV-1-infected cells using an improved reporter virus system reveals that p53 up-regulation occurs exclusively in the virus-expressing cell population. Virology 393 1 (2009) 160-167
27. Jaramillo M., Gowda D.C., Radzioch D., and Olivier M. Hemozoin increases IFN-gamma-inducible macrophage nitric oxide generation through extracellular signal-regulated kinase- and NF-kappa B-dependent pathways. J. Immunol. 171 8 (2003) 4243-4253
28. Kamata M., Nitahara-Kasahara Y., Miyamoto Y., Yoneda Y., and Aida Y. Importin-alpha promotes passage through the nuclear pore complex of human immunodeficiency virus type 1 Vpr. J. Virol. 79 6 (2005) 3557-3564
29. Kedzierska K., and Crowe S.M. The role of monocytes and macrophages in the pathogenesis of HIV-1 infection. Curr. Med. Chem. 9 21 (2002) 1893-1903
30. Kodiha M., Banski P., Ho-Wo-Cheong D., and Stochaj U. Dissection of the molecular mechanisms that control the nuclear accumulation of transport factors importin-alpha and CAS in stressed cells. Cell. Mol. Life Sci. 65 11 (2008) 1756-1767
31. Kodiha M., Tran D., Qian C., Morogan A., Presley J.F., Brown C.M., and Stochaj U. Oxidative stress mislocalizes and retains transport factor importin-alpha and nucleoporins Nup153 and Nup88 in nuclei where they generate high molecular mass complexes. Biochim. Biophys. Acta 1783 3 (2008) 405-418
32. Kublin J.G., Patnaik P., Jere C.S., Miller W.C., Hoffman I.F., Chimbiya N., Pendame R., Taylor T.E., and Molyneux M.E. Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study. Lancet 365 9455 (2005) 233-240
33. Levy D.N., Aldrovandi G.M., Kutsch O., and Shaw G.M. Dynamics of HIV-1 recombination in its natural target cells. Proc. Natl. Acad. Sci. U.S.A. 101 12 (2004) 4204-4209
34. Lipford J.R., Worland S.T., and Farnet C.M. Nucleotide binding by the HIV-1 integrase protein in vitro. J. Acquir. Immune Defic. Syndr. 7 12 (1994) 1215-1223
35. Lorsbach R.B., Murphy W.J., Lowenstein C.J., Snyder S.H., and Russell S.W. Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing. Molecular basis for the synergy between interferon-gamma and lipopolysaccharide. J. Biol. Chem. 268 3 (1993) 1908-1913
36. Lyke K.E., Diallo D.A., Dicko A., Kone A., Coulibaly D., Guindo A., Cissoko Y., Sangare L., Coulibaly S., Dakouo B., Taylor T.E., Doumbo O.K., and Plowe C.V. Association of intraleukocytic Plasmodium falciparum malaria pigment with disease severity, clinical manifestations, and prognosis in severe malaria. Am. J. Trop. Med. Hyg. 69 3 (2003) 253-259
37. Mantovani A., Sica A., and Locati M. Macrophage polarization comes of age. Immunity 23 4 (2005) 344-346
38. Maréchal V., Prevost M.C., Petit C., Perret E., Heard J.M., and Schwartz O. Human immunodeficiency virus type 1 entry into macrophages mediated by macropinocytosis. J. Virol. 75 22 (2001) 11166-11177
39. McDonald D., Vodicka M.A., Lucero G., Svitkina T.M., Borisy G.G., Emerman M., and Hope T.J. Visualization of the intracellular behavior of HIV in living cells. J. Cell. Biol. 159 3 (2002) 441-452
40. McGilvray I.D., Serghides L., Kapus A., Rotstein O.D., and Kain K.C. Nonopsonic monocyte/macrophage phagocytosis of Plasmodium falciparum-parasitized erythrocytes: a role for CD36 in malarial clearance. Blood 96 9 (2000) 3231-3240
41. Millington O.R., Gibson V.B., Rush C.M., Zinselmeyer B.H., Phillips R.S., Garside P., and Brewer J.M. Malaria impairs T cell clustering and immune priming despite normal signal 1 from dendritic cells. PLoS Pathog. 3 10 (2007) 1380-1387
42. Miyamoto Y., Saiwaki T., Yamashita J., Yasuda Y., Kotera I., Shibata S., Shigeta M., Hiraoka Y., Haraguchi T., and Yoneda Y. Cellular stresses induce the nuclear accumulation of importin alpha and cause a conventional nuclear import block. J. Cell. Biol. 165 5 (2004) 617-623
43. Moller W., Hofer T., Ziesenis A., Karg E., and Heyder J. Ultrafine particles cause cytoskeletal dysfunctions in macrophages. Toxicol. Appl. Pharmacol. 182 3 (2002) 197-207
44. Moore J.M., Chaisavaneeyakorn S., Perkins D.J., Othoro C., Otieno J., Nahlen B.L., Shi Y.P., and Udhayakumar V. Hemozoin differentially regulates proinflammatory cytokine production in human immunodeficiency virus-seropositive and -seronegative women with placental malaria. Infect. Immun. 72 12 (2004) 7022-7029
45. Moormann A.M., Sullivan A.D., Rochford R.A., Chensue S.W., Bock P.J., Nyirenda T., and Meshnick S.R. Malaria and pregnancy: placental cytokine expression and its relationship to intrauterine growth retardation. J. Infect. Dis. 180 6 (1999) 1987-1993
46. Nitahara-Kasahara Y., Kamata M., Yamamoto T., Zhang X., Miyamoto Y., Muneta K., Iijima S., Yoneda Y., Tsunetsugu-Yokota Y., and Aida Y. Novel nuclear import of Vpr promoted by importin alpha is crucial for human immunodeficiency virus type 1 replication in macrophages. J. Virol. 81 10 (2007) 5284-5293
47. Noland G.S., Briones N., and Sullivan Jr. D.J. The shape and size of hemozoin crystals distinguishes diverse Plasmodium species. Mol. Biochem. Parasitol. 130 2 (2003) 91-99
48. Nti B.K., Slingluff J.L., Keller C.C., Hittner J.B., Ong'echa J.M., Murphey-Corb M., and Perkins D.J. Stage-specific effects of Plasmodium falciparum-derived hemozoin on blood mononuclear cell TNF-alpha regulation and viral replication. AIDS 19 16 (2005) 1771-1780
49. Olliaro P., Lombardi L., Frigerio S., Basilico N., Taramelli D., and Monti D. Phagocytosis of hemozoin (native and synthetic malaria pigment), and Plasmodium falciparum intraerythrocyte-stage parasites by human and mouse phagocytes. Ultrastruct. Pathol. 24 1 (2000) 9-13
50. Ouellet M., Roy J., Barbeau B., Geleziunas R., and Tremblay M.J. NF-kappaB induction by bisperoxovanadium compounds requires CD45, p36(LAT), PKC, and IKK activity and exhibits kinetics of activation comparable to those of TCR/CD28 coengagement. Biochemistry 42 27 (2003) 8260-8271
51. Pagola S., Stephens P.W., Bohle D.S., Kosar A.D., and Madsen S.K. The structure of malaria pigment beta-haematin. Nature 404 6775 (2000) 307-310
52. Perelson A.S., Neumann A.U., Markowitz M., Leonard J.M., and Ho D.D. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271 5255 (1996) 1582-1586
53. Pisciotta J.M., Coppens I., Tripathi A.K., Scholl P.F., Shuman J., Bajad S., Shulaev V., and Sullivan Jr. D.J. The role of neutral lipid nanospheres in Plasmodium falciparum haem crystallization. Biochem. J. 402 1 (2007) 197-204
54. Pisciotta J.M., and Sullivan D. Hemozoin: oil versus water. Parasitol. Int. 57 2 (2008) 89-96
55. Schwarzer E., Turrini F., Ulliers D., Giribaldi G., Ginsburg H., and Arese P. Impairment of macrophage functions after ingestion of Plasmodium falciparum-infected erythrocytes or isolated malarial pigment. J. Exp. Med. 176 4 (1992) 1033-1041
56. Schwarzer E., Alessio M., Ulliers D., and Arese P. Phagocytosis of the malarial pigment, hemozoin, impairs expression of major histocompatibility complex class II antigen, CD54, and CD11c in human monocytes. Infect. Immun. 66 4 (1998) 1601-1606
57. Skinner-Adams T.S., McCarthy J.S., Gardiner D.L., and Andrews K.T. HIV and malaria co-infection: interactions and consequences of chemotherapy. Trends Parasitol 24 6 (2008) 264-271
58. Staudinger R., Abraham N.G., Levere R.D., and Kappas A. Inhibition of human immunodeficiency virus-1 reverse transcriptase by heme and synthetic heme analogs. Proc. Assoc. Am. Physicians 108 1 (1996) 47-54
59. Steckbeck J.D., Orlov I., Chow A., Grieser H., Miller K., Bruno J., Robinson J.E., Montelaro R.C., and Cole K.S. Kinetic rates of antibody binding correlate with neutralization sensitivity of variant simian immunodeficiency virus strains. J. Virol. 79 19 (2005) 12311-12320
60. Stuehr D.J., and Marletta M.A. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc. Natl. Acad. Sci. U.S.A. 82 22 (1985) 7738-7742
61. Sullivan Jr. D.J., Gluzman I.Y., Russell D.G., and Goldberg D.E. On the molecular mechanism of chloroquine's antimalarial action. Proc. Natl. Acad. Sci. U.S.A. 93 21 (1996) 11865-11870
62. Suzuki Y., Misawa N., Sato C., Ebina H., Masuda T., Yamamoto N., and Koyanagi Y. Quantitative analysis of human immunodeficiency virus type 1 DNA dynamics by real-time PCR: integration efficiency in stimulated and unstimulated peripheral blood mononuclear cells. Virus Genes 27 2 (2003) 177-188
63. Taramelli D., Monti D., Omodeo-Sale F., Basilico N., Parapini S., Pasini E., Lombardi L., and Olliaro O. Ultrastructural characteristics, biological activity and pharmacological relevance of synthetic malaria pigment (beta-haematin). Parassitologia 43 Suppl 1 (2001) 45-49
64. Taramelli D., Recalcati S., Basilico N., Olliaro P., and Cairo G. Macrophage preconditioning with synthetic malaria pigment reduces cytokine production via heme iron-dependent oxidative stress. Lab. Invest. 80 12 (2000) 1781-1788
65. Vodicka M.A., Koepp D.M., Silver P.A., and Emerman M. HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection. Genes Dev. 12 2 (1998) 175-185
66. WHO (2002). World Malaria report 2005.
67. WHO (2007). Global HIV prevalence has levelled off.
68. Yi Y., Loftin L., Wang L., Ratcliffe S.J., Isaacman-Beck J., and Collman R.G. Entry coreceptor use and fusion inhibitor T20 sensitivity of dual-tropic R5X4 HIV-1 in primary macrophage infection. J. Acquir. Immune Defic. Syndr. 47 3 (2008) 285-292
69. Zack J.A., Arrigo S.J., Weitsman S.R., Go A.S., Haislip A., and Chen I.S. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61 2 (1990) 213-222